A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Elevated hsCRP
Clinical trial NCT06031844 · COMPLETED
Trial details
- NCT number
- NCT06031844
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2024-12-17
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.